Understanding the Goal: Dormancy, Not Elimination

Epstein-Barr virus (EBV) is a lifelong passenger in over 90% of adults. Once infected, you can’t eradicate it — but your immune system is designed to keep it suppressed in a dormant (latent) state. Reactivation happens when that immune surveillance breaks down: under chronic stress, immune dysregulation, illness (including COVID-19), or nutritional deficiencies, the virus can shift from latency into its active lytic cycle, causing debilitating symptoms.

The strategy, then, is not to eliminate EBV but to restore the immune environment that keeps it contained. The supplements below each contribute to that goal through different but complementary mechanisms.

1. Mitopure (Urolithin A) — Restoring Immune Cell Fitness

Mitopure is a purified form of urolithin A that activates mitophagy — the process by which damaged mitochondria are cleared and replaced. This matters for EBV specifically because the virus is kept latent by NK cells and CD8+ cytotoxic T cells, and both of these cell types are highly dependent on mitochondrial energy metabolism to function effectively.

In a recent randomized, placebo-controlled clinical trial (the MitoImmune study), urolithin A supplementation in healthy adults significantly increased circulating NK cells and nonclassical monocytes, enhanced CD8+ T cell mitochondrial biogenesis and activation, and produced broad transcriptional shifts across immune cell populations. Since EBV reactivation is fundamentally a failure of NK and CD8+ T cell surveillance over latently infected B cells, improving the metabolic fitness of these populations is a mechanistically rational strategy for supporting viral re-suppression. Timeline is offering 20% off Mitopure (Urolithin A) at the moment if you are interested in trying it.  The four month trials on Urolithin A and restoring damaged mitochondria are incredibly encouraging. I am personally on my third month of taking it.

2. Beta-Glucan — Activating Innate Immune Surveillance

Beta-glucan is a polysaccharide found in the cell walls of yeast, oats, and mushrooms (particularly varieties like reishi and shiitake). It is one of the most well-studied natural immunomodulators available.

Beta-glucans are recognized by the innate immune system, and this recognition plays important roles in host defense and presents specific opportunities for clinical modulation of the host immune response — with neutrophils, macrophages, and dendritic cells all expressing receptors capable of recognizing beta-glucan. Beta-glucan has been found to affect several types of immune cells, including macrophages, natural killer cells, and neutrophils, resulting in various immunological effects.

For EBV specifically, NK cell activation is central to the goal of re-establishing viral dormancy. Beta-glucan’s documented ability to prime NK cells and enhance macrophage function supports the immune surveillance network that constrains latent EBV. More recently, there has been mounting evidence that beta-glucan functions as a physiologically active “biological response modulator,” promoting dendritic cell maturation, cytokine secretion, and regulating adaptive immune responses.

3. Vitamin C — Antiviral and Immune Support

Vitamin C has one of the most documented antiviral track records of any supplement, and its relevance to herpesvirus control is well-established. Since viral infections are often associated with oxidative stress, the ability of ascorbate to promote a reducing environment could be important in detoxification and neutralization of reactive oxygen species associated with infection.

High-dose intravenous vitamin C has been studied directly in EBV infection, and millimolar concentrations of ascorbate or dehydroascorbate have dramatically reduced the ability of herpes simplex virus type 1 and other viral types to infect cell monolayers. While IV dosing achieves concentrations not reachable orally, even oral supplementation provides meaningful antioxidant and immune support. Vitamin C is a cofactor in the viral immune system — supporting neutrophil function, interferon production, and lymphocyte activity. Typical oral doses used clinically for immune support range from 500–2,000 mg daily. Talk to your doctor about dosing.

4. L-Lysine — The Classic Anti-Herpesvirus Amino Acid

L-lysine has been used for decades in the management of herpes simplex virus, and its relevance to EBV is extrapolated from the same basic biology: all herpesviruses compete for arginine, an amino acid they require for viral replication. Lysine competes with arginine for intestinal absorption and cellular uptake, effectively starving the virus of a key replication resource.

While direct clinical trials for lysine in EBV are lacking, some patients with reactivated EBV have reported benefit from monolaurin, L-lysine, antiviral herbs, and high dose vitamin C. Commonly reported protocols combine lysine 500 mg with olive leaf extract, taken twice daily. The rationale is mechanistically sound given EBV’s membership in the herpesvirus family, and the safety profile of L-lysine supplementation is excellent at typical doses.

5. Zinc — Disrupting Viral Replication

Zinc plays a critical, multifaceted role in antiviral immunity and is perhaps the most extensively studied micronutrient in the context of herpesvirus control. The effect of zinc on herpesviruses has been studied for over 40 years, with in vitro studies suggesting that zinc plays an inhibitory role on almost every aspect of the viral life cycle: viral polymerase function, protein production and processing, and free virus inactivation.

Clinical trials have reported that systemic zinc supplementation significantly reduces the severity and recurrence of herpes labialis and genital herpes. Zinc also directly supports NK cell and T cell function — the key immune populations responsible for EBV surveillance. Zinc deficiency is common and often overlooked; correcting it can meaningfully improve antiviral immune capacity. Typical supplemental doses range from 15–30 mg elemental zinc daily (with attention to copper balance with longer-term use).

6. Quercetin — Directly Blocking EBV Entry and Replication

Quercetin is a flavonoid found abundantly in apples, onions, capers, and tea. It has some of the most specific published evidence of any natural compound for EBV inhibition. Quercetin isolated from licorice has been shown to interfere with the recognition of EBV receptors such as CD21, CD35, and HLAII in gastric cells and consequently block EBV entry; additionally, quercetin limits EBV infection in coinfected gastric and lymphoblastoid cells.

Quercetin has studies showing its ability to help the body fight the early antigen of the Epstein-Barr virus, with doses of 1,000–1,200 mg daily commonly referenced. Beyond its direct antiviral activity, quercetin’s anti-inflammatory and antioxidant properties help reduce the oxidative stress environment that promotes viral reactivation.

7. Monolaurin — Disrupting the Viral Envelope

Monolaurin is a monoglyceride derived from lauric acid (the same fatty acid responsible for much of coconut oil’s antiviral activity). It works by a uniquely direct mechanism: it disrupts the lipid envelope of enveloped viruses like EBV, impairing their ability to infect host cells and replicate. This membrane-active mechanism is distinct from immune modulation — it acts more directly on the virus itself.

While human clinical trial data for EBV specifically is limited, monolaurin is a well-established antiviral compound with documented activity against multiple enveloped viruses, and it is one of the most commonly reported supplements among patients managing chronic EBV reactivation. Start low and titrate up gradually, as die-off effects from viral cell clearance can occur.

8. Olive Leaf Extract — Broad-Spectrum Antiviral

Olive leaf extract (standardized to oleuropein) is a botanical with documented antiviral activity across multiple viral families. Oleuropein has been shown to inhibit viral replication by interfering with viral protein production and preventing viral entry into host cells. It is frequently combined with L-lysine in clinical practice for EBV and other herpesvirus management, as the two compounds appear to work synergistically through complementary mechanisms.

9. NAC (N-Acetyl Cysteine) — Reducing the Oxidative Trigger

EBV reactivation is significantly driven by oxidative stress — reactive oxygen species (ROS) act as a molecular switch that can shift the virus from latency to its lytic cycle. NAC is a glutathione precursor and one of the most potent readily available antioxidants. By replenishing intracellular glutathione and reducing ROS levels, NAC addresses one of the core triggers of EBV reactivation. NAC is an antioxidant that can also help with nerve function and memory — two areas commonly affected during EBV reactivation. Typical doses range from 600–1,200 mg daily.

Putting It Together: A Layered Approach

No single supplement is likely to be sufficient on its own. The most rational strategy is layered — addressing the problem from multiple angles simultaneously:

• Immune surveillance restoration: Mitopure, Beta-Glucan, Zinc
• Direct antiviral activity: Quercetin, Monolaurin, Olive Leaf Extract, Kaempferol
• Arginine competition/replication suppression: L-Lysine
• Oxidative stress reduction (removes a key reactivation trigger): Vitamin C, NAC

Lifestyle factors matter equally: adequate sleep, stress management, reduction of processed sugar and alcohol (which impair immune function), and avoidance of immune-depleting medications when possible.

For patients with documented EBV reactivation — particularly in the setting of long COVID — this type of comprehensive supplement strategy is increasingly discussed by functional medicine and integrative practitioners. Clinical guidance from a knowledgeable provider familiar with EBV reactivation is strongly recommended before initiating any protocol.

Check out my second edition of Eat Pray Get Well – A Journey from Chronic Illness & Brokenness to Wholeness & Healing NOW ON KINDLE FOR $9.99.

I’m still in awe of what God will do.  My book is placed in between Reese Witherspoon’s and Joanna Gaines book at the book store!

Recent Post